And for more information, visit Prime's GLP-1 Strategy page. Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management ...

That represents a 46% jump over the average annual medical cost of $12,695 prior to taking the medication, data provided by pharmacy benefits manager Prime Therapeutics show. The costs for a ...

In a report released yesterday, Joseph Thome from TD Cowen maintained a Buy rating on Prime Medicine, Inc. (PRME – Research Report). The ...

ADMINISTRATIVE: The operational costs of running a campaign or PAC, including travel expenses, office rent and supplies, utilities, equipment, food, meetings, and administrative services such as ...

Encouraging Preclinical Data: Decoy20 has produced efficacy in preclinical studies across a variety of tumor types and in combination with four different classes of existing drugs, demonstrating both ...

Thank you for standing by. My name is John, and I’ll be your conference operator today. At this time I would like to welcome everyone to the Allurion Third Quarter Earnings Call. All lines have been ...

Adaptimmune Therapeutics is prepping for another FDA submission after ... facing a devastating disease with limited ...

Cathie Wood's ARK Innovation ETF (ARKK) has surged to its highest trading level in more than two years this week, surpassing ...

Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

A review by pharmacy benefit manager Prime Therapeutics, and reported by Reuters, found that patients with obesity incurred average annual medical costs of $18,507 two years after starting GLP-1 ...